Instil Bio TIL
NASDAQ TIL
$7.58 +0.15 (+2.02%)
As of: Aug 21, 2026 · 3:52 PM EDT

Instil Bio (TIL) Other Accumulated Expenses (2020 - 2024)

Instil Bio (TIL) posted quarterly Other Accumulated Expenses of $107000.0 for Q3 2024, down 66.98% year-over-year from $324000.0 in Q4 2023, and down 25.17% quarter-over-quarter from $143000.0 in Q2 2024.

Instil Bio (TIL) Other Accumulated Expenses (2020 - 2024) Analysis & Trends

Instil Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $107000.0 for Q3 2024.

  • In Q3 2024, Other Accumulated Expenses fell 66.98% year-over-year to $107000.0; the TTM figure through Sep 2024 stood at $107000.0 (down 66.98% YoY), while the FY2023 annual figure was $190000.0, down 67.91% from the prior year.
  • Other Accumulated Expenses for Q3 2024 stood at $107000.0, down from $143000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $933000.0 in Q3 2022, with the low at $107000.0 in Q3 2024.
  • The 5-year median for Other Accumulated Expenses is $302500.0 (2020), against an average of $381937.5.
  • The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses surged 361.66% in 2022, then tumbled 73.1% in 2024.
  • Instil Bio's Other Accumulated Expenses stood at $281000.0 in 2020, then jumped by 37.37% to $386000.0 in 2021, then surged by 53.37% to $592000.0 in 2022, then sank by 67.91% to $190000.0 in 2023, then sank by 43.68% to $107000.0 in 2024.
  • Business Quant data shows TIL's Other Accumulated Expenses at $107000.0 in Q3 2024, $143000.0 in Q2 2024, and $145000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Instil Bio 51.68 Mn 51.68 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 107,000.00
Jun 30, 2024 143,000.00
Mar 31, 2024 145,000.00
Dec 31, 2023 190,000.00
Sep 30, 2023 324,000.00
Jun 30, 2023 339,000.00
Mar 31, 2023 539,000.00
Dec 31, 2022 592,000.00
Sep 30, 2022 933,000.00
Jun 30, 2022 891,000.00
Mar 31, 2022 643,000.00
Dec 31, 2021 386,000.00
Sep 30, 2021 234,000.00
Jun 30, 2021 193,000.00
Mar 31, 2021 171,000.00
Dec 31, 2020 281,000.00